Connect with us

Legal & Regulation

Washington, D.C. Starts Medical Cannabis Program to Cardholders from 8 States

Denis

Published

on

Washington, D.C. Starts Medical Cannabis Program to Cardholders from 8 States

In a “patient-centric” emergency rulemaking, Washington, D.C. has opened its medical marijuana program to cardholders from other states.

This new program is not dependent on whether the other states accept medical marijuana cards from the district.

Dispensaries in D.C. will accept cards from New York, Vermont, New Mexico, Nevada, California, Arkansas, Arizona, and Alaska.

West Virginia, Oklahoma, Minnesota, and Louisiana are still under review.

In a press release, Mayor Muriel Bowser said that the program ensures that medical cannabis patients from other states can get their medicine when needed. This will also play a significant role in promoting public safety by allowing visitors to get their medicine at one of the 6 authorized dispensaries in the district rather than patronizing the illegal cannabis market.

Already, the program accepts marijuana cards from Washington, Colorado, Florida, Delaware, Illinois, Hawaii, Maryland, Maine, Ohio, North Dakota, Pennsylvania, Massachusetts, New Jersey, Rhode Island, Michigan, Oregon, New Hampshire, Montana, and Connecticut.

This is the most recent move by Bowser to expand the cannabis footprint in D.C. In May, Bowser proposed a Cannabis Sales Act that would regulate the taxed cannabis industry. Voters approved cannabis legalization in 2015, but the federal law dictates Washington, D.C.’s policy and officials are yet to implement any recreational cannabis sales programs.

Under the new plan by Bowser, residents should comprise 60% of adult-use cannabis business, and 60% of the employees should come from the district. This measure would impose a 17% tax on recreational marijuana products.

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

Join Us On Facebook

Advertisement

Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?

Advertisement